Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OBN Digital CEO Interview: Meet the Finalists, OBN Awards 2020 - Best Established Biotech Company flyer

Join OBN to learn more about the OBN Awards 2020 finalists for Best Established Biotech Company: 

Absolute Antibody – who has developed a proprietary manufacturing platform based on transient transfection for the production of sequenced and engineered antibodies, AbsoluteAbs (AbAbs) 

C4X Discovery –  exploit cutting edge technologies to design and create small-molecule candidates in a range of therapeutic areas 

Exscientia - automate drug discovery and design processes leveraging artificial intelligence and big data

John will interview each finalist in turn, aiming to share more about the company’s story, their R&D Innovation and why they are making such an impact on the industry today.  We will also hear a few words from our sponsor, Precision for Medicine who are kindly supporting and presenting this award category. 

Click here to register (waiting for link)

The OBN Awards, are the most highly regarded awards event in the industry and aim to recognise and celebrate the most innovative life sciences companies across all therapy areas and functions.